# CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/CRSP/crispr-therapeutics-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference
Ticker: CRSP
Company: CRISPR Therapeutics
Source: CRISPR Therapeutics
Published: 2026-01-05 13:30 EST
Original Source URL: https://ir.crisprtx.com
## Summary

ZUG , Switzerland and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team will present at the 44th Annual

## Article Body
ZUG , Switzerland and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team will present at the 44th Annual
## Recent Company News
- 2026-05-28 12:00 EST — [CRISPR Therapeutics to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/CRSP/crispr-therapeutics-to-participate-in-upcoming-investor-conferences) — Source: CRISPR Therapeutics
- 2026-05-06 12:30 EST — [CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference](https://biopharmsignal.com/news/CRSP/crispr-therapeutics-to-present-at-the-bank-of-america-securities-2026-global-healthcare-conference) — Source: CRISPR Therapeutics
- 2026-05-04 20:30 EST — [CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/CRSP/crispr-therapeutics-provides-business-update-and-reports-first-quarter-2026-financial-results) — Source: CRISPR Therapeutics
- 2026-04-07 12:00 EST — [CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/CRSP/crispr-therapeutics-to-present-at-the-25th-annual-needham-virtual-healthcare-conference) — Source: CRISPR Therapeutics
- 2026-03-11 11:00 EST — [CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering](https://biopharmsignal.com/news/CRSP/crispr-therapeutics-prices-upsized-convertible-senior-notes-offering) — Source: CRISPR Therapeutics
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)